Feasibility of Remote eCTG Monitoring Home@Hospital in Complicated Pregnancies

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMaxima Medical Center

About this trial

The objective of this single center, interventional cohort study is to evaluate the feasibility of remote electrophysiological cardiotocography (eCTG) monitoring in complicated pregnancies in a home@hospital setting.

The primary objective is to assess:

• The success rate of the self-administered eCTG measurement

The secondary objective is to asses:

* Maternal and perinatal outcomes * Patients wellbeing and satisfaction. * Healthcare professionals' (HCPs') satisfaction * Analysis of antenatal costs

Participants will:

* Self-administer remote eCTG monitoring once daily during admission (or at least twice weekly at the outpatient clinic) * Self-measure their blood pressure, heartrate and temperature * Enter the measurements, symptoms and worries into an application on their telephone. * Answer questionnaires at 3 moments during the study, assessing their wellbeing and satisfaction of the received care and self-administered remote monitoring device.

Eligibility criteria

Qualifiers

Minimum age of 18 years old

Pregnant patients with a gestational age between 32+0 and 36+6 weeks and days

Singleton pregnancy

Pre-eclampsia (PE)

Disqualifiers

Oral and written informed consent is obtained.

An indication for intravenous medication

Blood pressure >160/110 A millimeter of mercury (mmHg)

Absent-/or reversed flow umbilical artery Doppler

Trial design

Treatments tested in this trial

  • Remote eCTG

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Maxima Medical Center

Lead sponsor

Eindhoven University of Technology

Collaborator